Saturday, July 11, 2026

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 74 of 114
  1. PROpel D081SC00001

    AstraZeneca AB

    Metastatic castration-resistant prostate cancer

    phase 3 small molecule active

    1 trial
  2. PRX-102

    Protalix BioTherapeutics

    Fabry Disease

    phase 3 small molecule completed

    2 trials
  3. PRX-102 (pegunigalsidase alfa)

    Protalix BioTherapeutics

    Fabry Disease

    phase 3 mab completed

    3 trials
  4. PS0021

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis

    phase 3 small molecule active

    1 trial
  5. PSK00010

    Sanofi-aventis Healthcare Pty Ltd

    Pneumococcal immunisation

    phase 3 small molecule active

    1 trial
  6. PSK04

    Sanofi-aventis Healthcare Pty Ltd

    Pneumococcal Immunization

    phase 3 small molecule active

    1 trial
  7. PSMA-11 kit for Ga-68 labelling

    Bial Portela & Companhia S.A.

    Intermediate and high-risk prostate cancer

    phase 3 small molecule active

    1 trial
  8. PTC299

    PTC THERAPEUTICS, INC.

    Pneumonia

    phase 3 small molecule terminated

    1 trial
  9. PTC923

    PTC THERAPEUTICS, INC.

    Phenylketonuria

    phase 3 small molecule active

    2 trials
  10. PTC923, PTC923

    PTC THERAPEUTICS, INC.

    Metabolic Disorders - Phenylketonuria

    phase 3 small molecule active

    1 trial
  11. PTC923-PKU-301

    PTC THERAPEUTICS, INC.

    Phenylketonuria

    phase 3 small molecule active

    1 trial
  12. PTC923-PKU-401

    PTC THERAPEUTICS, INC.

    Phenylketonuria

    phase 3 small molecule active

    1 trial
  13. PTH/Calcium

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial
  14. PTX-022

    PALVELLA THERAPEUTICS, INC.

    Pachyonychia Congenita

    phase 3 small molecule active

    3 trials
  15. PV-10 (10% rose bengal disodium)

    PROVECTUS BIOPHARMACEUTICALS, INC.

    Cutaneous Melanoma

    phase 3 small molecule terminated

    1 trial
  16. PVRV

    Sanofi Pasteur

    Rabies

    phase 3 mab completed

    1 trial
  17. Paclitaxel

    The First People's Hospital of Lianyungang

    Esophageal Cancer

    phase 3 small molecule active

    1 trial
  18. Paclitaxel

    Cellectar Biosciences

    Non Small Cell Lung Cancer

    phase 3 small molecule completed

    1 trial
  19. Paclitaxel dosing according to SmPC

    BRIGHT MINDS BIOSCIENCES INC.

    Carcinoma, Non-Small-Cell Lung

    phase 3 small molecule completed

    1 trial
  20. Paclitaxel eluting PTCA balloon

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary In-stent Restenosis

    phase 3 other active

    1 trial
  21. Paclitaxel or docetaxel + Cisplatin or carboplatin

    The First People's Hospital of Lianyungang

    Uterine Cervical Neoplasms

    phase 3 small molecule active

    1 trial
  22. Paclitaxel, Cisplatin Plus 5-FU (TCF)

    The First People's Hospital of Lianyungang

    Esophageal Cancer Stage IIB

    phase 3 other active

    1 trial
  23. Paclitaxel-releasing PTA balloon catheter

    Lxo Ireland Designated Activity Company

    Arteriovenous Fistula Renal Dialysis Devices Obstruction

    phase 3 other completed

    1 trial
  24. Pacritinib

    Swedish Orphan Biovitrum AB (publ)

    Primary Myelofibrosis

    phase 3 small molecule active

    1 trial
  25. Paeoniflorin + phosphatidylcholine or silymarin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis, Autoimmune

    phase 3 small molecule terminated

    1 trial
  26. Palazestrant

    Olema Pharmaceuticals

    Breast Cancer

    phase 3 small molecule active

    3 trials
  27. Palbociclib

    Pfizer

    Metastatic Breast Cancer

    phase 3 small molecule completed

    1 trial
  28. Paliperidone palmitate

    Janssen Cilag International NV

    Schizophrenia

    phase 3 small molecule completed

    2 trials
  29. Palliative Chemotherapy

    Sun Yat-sen University

    Colorectal Neoplasms Malignant

    phase 3 small molecule active

    1 trial
  30. Paltusotine

    Crinetics Pharmaceuticals Europe GmbH

    Acromegaly

    phase 3 small molecule active

    5 trials
  31. Paltusotine

    Crinetics Pharmaceuticals Europe GmbH

    Carcinoid Syndrome

    phase 3 small molecule active

    1 trial
  32. Pamiparib capsule

    BEONE MEDICINES AUS PTY LTD

    Ovarian Cancer

    phase 3 small molecule active

    1 trial
  33. Pamiparib capsule

    BeiGene

    Ovarian Cancer

    phase 3 small molecule active

    1 trial
  34. Panitumumab

    Amgen

    Metastatic Colorectal Cancer

    phase 3 small molecule completed

    1 trial
  35. Panitumumab-3001

    Takeda

    Colorectal Cancer

    phase 3 small molecule completed

    1 trial
  36. Panobinostat

    Novartis Pharmaceuticals

    Multiple Myeloma

    phase 3 small molecule completed

    1 trial
  37. Pantoprazole

    Takeda

    Gastroesophageal Reflux Disease (GERD)

    phase 3 small molecule completed

    2 trials
  38. Pantoprazole

    Takeda

    GERD

    phase 3 small molecule completed

    1 trial
  39. Pantoprazole (Pantoloc)

    Hospital Authority, Hong Kong

    Peptic Ulcers

    phase 3 small molecule active

    1 trial
  40. Paracetamol/Ibuprofen Vale 1000 mg/300 mg oldatos infúzió

    Lacuna Pharma Pty Ltd

    Acute pain

    phase 3 small molecule active

    1 trial
  41. Parathyroid Hormone (PTH)

    Takeda

    Osteoporosis

    phase 3 small molecule completed

    1 trial
  42. Parathyroid hormone

    Takeda

    Disruption or Dehiscence of Closure of Sternum or Sternotomy

    phase 3 small molecule completed

    1 trial
  43. Part A: Upamostat 200 mg

    RedHill Biopharma

    Covid19

    phase 3 small molecule terminated

    1 trial
  44. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    Biotech Pharmaceutical Co.,

    Influenza

    phase 3 mab active

    1 trial
  45. Participants will receive one dose of vaccine (0.5 mL) of Sinovac QIV

    Sinovac Research and Development Co.,

    Influenza

    phase 3 mab active

    1 trial
  46. Patisiran

    Alnylam Netherlands B.V.

    Amyloidosis

    phase 3 small molecule completed

    1 trial
  47. Patisiran

    Alnylam Netherlands B.V.

    Amyloidosis, Familial

    phase 3 small molecule completed

    1 trial
  48. Patisiran

    Alnylam Netherlands B.V.

    Amyloidosis, Hereditary

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.